The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Thyroid Hormone Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Thyroid Hormone Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1750291

No of Pages : 102

Ask Your Query

Synopsis
The global Thyroid Hormone Therapy market size was valued at USD 4662.2 million in 2022 and is forecast to a readjusted size of USD 5501.3 million by 2029 with a CAGR of 2.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

One of the key drivers of the thyroid hormone replacement therapy market is the increasing prevalence of hypothyroidism worldwide. Hypothyroidism is a common endocrine disorder, and its prevalence is rising due to factors such as aging populations, lifestyle changes, and improved detection and diagnosis. This growing prevalence of hypothyroidism is creating a larger patient pool requiring thyroid hormone replacement therapy, thereby driving the demand for related medications and treatments. Additionally, advancements in healthcare infrastructure, increased awareness about thyroid disorders, and expanding access to healthcare services in developing regions are further contributing to the growth of the thyroid hormone replacement therapy market.

Thyroid hormone replacement therapy is the primary treatment for hypothyroidism, a condition characterized by an underactive thyroid gland. The goal of this therapy is to restore normal thyroid hormone levels in the body and alleviate symptoms. The most commonly prescribed medication for thyroid hormone replacement is levothyroxine sodium, a synthetic form of the hormone thyroxine (T4).

This report is a detailed and comprehensive analysis for global Thyroid Hormone Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Thyroid Hormone Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Thyroid Hormone Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Thyroid Hormone Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Thyroid Hormone Therapy market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Thyroid Hormone Therapy
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Thyroid Hormone Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie, Mylan Pharma, Merck, Pfizer and Lannett Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Thyroid Hormone Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Oral
  • Injection

Market segment by Application

  • Hypothyroidism
  • Hyperthyroidism

Market segment by players, this report covers

  • Abbvie
  • Mylan Pharma
  • Merck
  • Pfizer
  • Lannett Company
  • Novartis
  • Fresenius Kabi
  • IBSA Institut Biochimique
  • Piramal Critical Care
  • Abbott

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Thyroid Hormone Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Thyroid Hormone Therapy, with revenue, gross margin and global market share of Thyroid Hormone Therapy from 2018 to 2023.
Chapter 3, the Thyroid Hormone Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Thyroid Hormone Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Thyroid Hormone Therapy.
Chapter 13, to describe Thyroid Hormone Therapy research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Thyroid Hormone Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Thyroid Hormone Therapy by Type
1.3.1 Overview: Global Thyroid Hormone Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Thyroid Hormone Therapy Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Injection
1.4 Global Thyroid Hormone Therapy Market by Application
1.4.1 Overview: Global Thyroid Hormone Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hypothyroidism
1.4.3 Hyperthyroidism
1.5 Global Thyroid Hormone Therapy Market Size & Forecast
1.6 Global Thyroid Hormone Therapy Market Size and Forecast by Region
1.6.1 Global Thyroid Hormone Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Thyroid Hormone Therapy Market Size by Region, (2018-2029)
1.6.3 North America Thyroid Hormone Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Thyroid Hormone Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Thyroid Hormone Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Thyroid Hormone Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Thyroid Hormone Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Thyroid Hormone Therapy Product and Solutions
2.1.4 Abbvie Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbvie Recent Developments and Future Plans
2.2 Mylan Pharma
2.2.1 Mylan Pharma Details
2.2.2 Mylan Pharma Major Business
2.2.3 Mylan Pharma Thyroid Hormone Therapy Product and Solutions
2.2.4 Mylan Pharma Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan Pharma Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Thyroid Hormone Therapy Product and Solutions
2.3.4 Merck Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Thyroid Hormone Therapy Product and Solutions
2.4.4 Pfizer Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Lannett Company
2.5.1 Lannett Company Details
2.5.2 Lannett Company Major Business
2.5.3 Lannett Company Thyroid Hormone Therapy Product and Solutions
2.5.4 Lannett Company Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lannett Company Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Thyroid Hormone Therapy Product and Solutions
2.6.4 Novartis Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Thyroid Hormone Therapy Product and Solutions
2.7.4 Fresenius Kabi Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fresenius Kabi Recent Developments and Future Plans
2.8 IBSA Institut Biochimique
2.8.1 IBSA Institut Biochimique Details
2.8.2 IBSA Institut Biochimique Major Business
2.8.3 IBSA Institut Biochimique Thyroid Hormone Therapy Product and Solutions
2.8.4 IBSA Institut Biochimique Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 IBSA Institut Biochimique Recent Developments and Future Plans
2.9 Piramal Critical Care
2.9.1 Piramal Critical Care Details
2.9.2 Piramal Critical Care Major Business
2.9.3 Piramal Critical Care Thyroid Hormone Therapy Product and Solutions
2.9.4 Piramal Critical Care Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Piramal Critical Care Recent Developments and Future Plans
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Thyroid Hormone Therapy Product and Solutions
2.10.4 Abbott Thyroid Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Thyroid Hormone Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Thyroid Hormone Therapy by Company Revenue
3.2.2 Top 3 Thyroid Hormone Therapy Players Market Share in 2022
3.2.3 Top 6 Thyroid Hormone Therapy Players Market Share in 2022
3.3 Thyroid Hormone Therapy Market: Overall Company Footprint Analysis
3.3.1 Thyroid Hormone Therapy Market: Region Footprint
3.3.2 Thyroid Hormone Therapy Market: Company Product Type Footprint
3.3.3 Thyroid Hormone Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Thyroid Hormone Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Thyroid Hormone Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Thyroid Hormone Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Thyroid Hormone Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Thyroid Hormone Therapy Consumption Value by Type (2018-2029)
6.2 North America Thyroid Hormone Therapy Consumption Value by Application (2018-2029)
6.3 North America Thyroid Hormone Therapy Market Size by Country
6.3.1 North America Thyroid Hormone Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Thyroid Hormone Therapy Consumption Value by Type (2018-2029)
7.2 Europe Thyroid Hormone Therapy Consumption Value by Application (2018-2029)
7.3 Europe Thyroid Hormone Therapy Market Size by Country
7.3.1 Europe Thyroid Hormone Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
7.3.3 France Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Hormone Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Thyroid Hormone Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Thyroid Hormone Therapy Market Size by Region
8.3.1 Asia-Pacific Thyroid Hormone Therapy Consumption Value by Region (2018-2029)
8.3.2 China Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
8.3.5 India Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Thyroid Hormone Therapy Consumption Value by Type (2018-2029)
9.2 South America Thyroid Hormone Therapy Consumption Value by Application (2018-2029)
9.3 South America Thyroid Hormone Therapy Market Size by Country
9.3.1 South America Thyroid Hormone Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Hormone Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Thyroid Hormone Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Thyroid Hormone Therapy Market Size by Country
10.3.1 Middle East & Africa Thyroid Hormone Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Thyroid Hormone Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Thyroid Hormone Therapy Market Drivers
11.2 Thyroid Hormone Therapy Market Restraints
11.3 Thyroid Hormone Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Thyroid Hormone Therapy Industry Chain
12.2 Thyroid Hormone Therapy Upstream Analysis
12.3 Thyroid Hormone Therapy Midstream Analysis
12.4 Thyroid Hormone Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock